Clinical Trial Update: Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating co-administration of testosterone with PDE5 inhibitors in erectile dysfunction patients who do not respond to PDE5 inhibitors alone; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Hypogonadism

Drugs mentioned

• PDE5 inhibitors
• TESTOSTERONE (testosterone)

Snippet

Sponsor: SELARL du Dr Jacques BUVAT | Conditions: Erectile Dysfunction, Hypogonadism | Phase 3 | Status: COMPLETED